Escitalopram CYP2C19 Poor Metabolizer Risk

Assess escitalopram QTc prolongation and adverse event risk in CYP2C19 poor metabolizers. AUC 3-fold higher requiring dose cap at 10mg/day.

Use the full interactive calculator below, or

Related Calculators

Frequently Asked Questions